Pancreatic cancer: risk and preventive factors
- 138 Downloads
In Asian countries, the increasing incidence of obesity has only recently opened a debate that has been ongoing in the West for a long time, not only regarding its cardiovascular consequences, but also the relationship between obesity, non-alcoholic fatty liver disease (NAFLD), and cancer [1, 2].
In this context, the paper by Chang and colleagues examines the relationship between pancreatic cancer and NAFLD in a Chinese population, a topic on which there have been few studies, so far . These authors retrospectively analyzed 143 patients with pancreatic cancer vs 414 without cancer. They conclude that NAFLD and type 2 diabetes are risk factors independently associated with pancreatic cancer, and that the use of statins and aspirin is a protective factor against neoplasia. Despite the limits of a retrospective study, their paper leads to important considerations.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
This article not contain any studies with human participants or animals perfomed by any of the authors.
- 4.Włodarek D, Jerzy Podleśny JS (2007) Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. Roczniki Państwowego Zakładu 58(1):129Google Scholar
- 6.Soresi M, Noto D, Cefalù AB, Martini S, Vigna GB, Fonda M, Metabolic Syndrome Study Group et al (2013) Non-alcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society. Acta Diabetol 50(2):241–249. https://doi.org/10.1007/s00592-012-0406-1 CrossRefPubMedGoogle Scholar
- 8.Pacifico L, Di Martino M, Anania C, Andreoli GM, Bezzi M, Catalano C et al (2015) Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease. World J Gastroenterol 21(15):4688–4695. https://doi.org/10.3748/wjg.v21.i15.4688 CrossRefPubMedPubMedCentralGoogle Scholar